• Users Online: 60
  • Print this page
  • Email this page


 
 Table of Contents  
LETTER TO EDITOR
Year : 2020  |  Volume : 4  |  Issue : 3  |  Page : 150-151

Anosmia as a screening tool to detect asymptomatic patients with coronavirus disease 2019


Faculty of Medicine, Omar Al-Mukhtar University, Albaida, Libya; Spire Fylde Coast Hospital, Blackpool, England, UK

Date of Submission17-Jun-2020
Date of Acceptance28-Jun-2020
Date of Web Publication21-Sep-2020

Correspondence Address:
Dr. Anis Abobaker
Spire Fylde Coast Hospital, St Walburgas Road, Blackpool, FY3 8BP

Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/LJMS.LJMS_50_20

Rights and Permissions

How to cite this article:
Abobaker A. Anosmia as a screening tool to detect asymptomatic patients with coronavirus disease 2019. Libyan J Med Sci 2020;4:150-1

How to cite this URL:
Abobaker A. Anosmia as a screening tool to detect asymptomatic patients with coronavirus disease 2019. Libyan J Med Sci [serial online] 2020 [cited 2020 Oct 24];4:150-1. Available from: https://www.ljmsonline.com/text.asp?2020/4/3/150/295614



Dear Editor,

Patients with coronavirus disease 2019 (“COVID-19”) typically present with respiratory symptoms and febrile illness. However, many reports showed that a significant proportion of individuals who tested positive for COVID-19 were asymptomatic.[1],[2] It is argued that this percentage could be over-reported as patients who were classified as asymptomatic could have atypical symptoms which may not be recognized to be related to COVID-19. For instance, anosmia (loss of smell) has been recently reported as a possible clinical feature of COVID-19.[3],[4] Two-third of confirmed COVID-19 cases in Germany had anosmia, whereas one-third of patients with mild disease in South Korea had anosmia as the main presenting symptom.[4] Postviral anosmia represents 40% of all causes of anosmia.[4] Viruses causing common cold and upper respiratory tract infections, in addition to the previous generations of coronaviruses, are the common pathogenic cause of postviral anosmia.[4] That is why it is not unusual for the novel coronavirus (SARS-CoV-2) to cause anosmia. Although anosmia might occur in association with other classical features of COVID-19, at least one in six patients reported new onset anosmia in the absence of other symptoms.[3] Therefore, anosmia can be used as a clinical marker to detect asymptomatic patients with COVID-19.

Asymptomatic patients can be considered as a hidden source which facilitates the transmission of COVID-19 infection.[1],[4],[5] Therefore, early detection and self-isolation of asymptomatic patients might limit the spread of the infection.[1],[4],[5] Interestingly, the implementation of a large-scale strategy by testing the entire population of an isolated village in Italy (around 3000 people) identified large numbers of asymptomatic carriers of infection, which have been quarantined.[5] This approach reduced the incidence of infection in this village by 90% in just 10 days.[5] Applying similar strategy in cities with bigger population might not be feasible because of issues with test-kits availability. In addition, it can lead to wasting of the health-care system resources. Alternatively, anosmia can be used as a criterion to test as many people as possible to detect asymptomatic patients as 17% of them reported isolated anosmia.[3] This approach can be named as “targeted large-scale testing protocol,” which might be better than the random large-scale testing strategy in many aspects. First of all, the targeted approach has higher pretest probability, which means it helps to detect a higher percentage of asymptomatic patients. secondly, it is more practical approach to apply as it is more cost-effective compared with the random approach. The important question now is how to practically implement such a plan at a national level. This can be achieved by educating people to identify who noticed recent changes in their smell sensation, using online surveys, postletters, public posters, news and social media, and encouraging them to contact the local authorities to get tested.

In conclusion, the use of targeted large-scale testing strategy which is based on anosmia as a selection criterion can be applied at a national level to detect asymptomatic patients with COVID-19. Early isolation of asymptomatic patients could decrease both the spread and the severity of the epidemic.[5]

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Day M. Covid-19: Four fifths of cases are asymptomatic, China figures indicate. BMJ 2020;369:m1375.  Back to cited text no. 1
    
2.
Mizumoto K, Kagaya K, Zarebski A, Chowell G. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Eurosurveillance 2020;25: doi:10.2807/1560-7917.ES.2020.25.10.2000180.  Back to cited text no. 2
    
3.
Hopkins C, Surda P, Kumar N. Presentation of new onset anosmia during the COVID-19 pandemic. Rhinology 2020;58:295-8.  Back to cited text no. 3
    
4.
Hopkins C, Kumar N. Loss of sense of smell as marker of COVID-19 infection. Entuk. org; 2020. Available from: https://www.entuk.org/sites/default/files/files/Loss%20of%20sense%20of%20smell%20as%20marker%20of%20COVID.pdf. [Last accessed on 2020 May 01].  Back to cited text no. 4
    
5.
Day M. Covid-19: Identifying and isolating asymptomatic people helped eliminate virus in Italian village. BMJ 2020;368:m1165.  Back to cited text no. 5
    




 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article
References

 Article Access Statistics
    Viewed59    
    Printed4    
    Emailed0    
    PDF Downloaded18    
    Comments [Add]    

Recommend this journal


[TAG2]
[TAG3]
[TAG4]